Glaxon's Xeno Amino Sour Berries is a Protein category supplement, formulated as an 'Other Combinations' product with 13 ingredients. This blend includes clinically studied dosages of Chromium (500mcg) and Taurine (500mg), alongside 2500mg of Myo-Seq and 2500mg of BCAA Blend, aiming to support muscle function and recovery. However, some electrolytes such as Magnesium, Chloride, and Potassium are present in underdosed amounts. The product achieves an N+ Score of 71 and a 'C' grade, signifying good quality. It may be beneficial for athletes or active individuals seeking amino acid support with additional minerals, despite some electrolyte dosage limitations.
About This Product
Xeno Amino Sour Berries by Glaxon is a protein supplement containing 13 active ingredients. It has earned an N+ Score of 71/100 (Grade C).
Notable clinical-dose ingredients include Chromium, Taurine.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +2 ingredient(s) at clinical dose levels
- +Rich formula with 13 active ingredients
Weaknesses
- −No major weaknesses identified
Ingredient Analysis (13 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Magnesium | 24.000 mg | Under |
| Chromium | 500.000 mcg | Optimal |
| Total Carbohydrates | 1.000 Gram(s) | N/A |
| Sodium | 80.000 mg | N/A |
| Potassium | 47.000 mg | Under |
| Taurine | 500.000 mg | High |
| AstraGin | 12.500 mg | N/A |
| Hyaluronic Acid | 45.000 mg | N/A |
| Chloride | 121.000 mg | Under |
| Velositol | 1000.000 mg | N/A |
| Myo-Seq (Sequenced Amino Acid Blend) | 2500.000 mg | N/A |
| BCAA Blend | 2500.000 mg | N/A |
| Astrolyte Electrolyte Blend | 775.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.